Welcome to ABX-CRO

The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside.

QDOSE

News

ABX-CRO’s contribution to Telix’ successful ZIRCON trial featured in The Lancet Oncology

We are extremely proud that our central involvement in designing, execution and analysis of of the Telix ZIRCON pivotal phase III study was recently recognised in The Lancet Oncology.This prospective, open-label, multicentre study evaluated the clinical utility of...

ABX-CRO is an official IHK training company

This summer we welcome our first two trainees. We look forward to seeing them learn and grow!!

QDOSE to be part of commercial partnership with Telix

We are proud to announce that the dosimetry software QDOSE® designed by us and our development partner Quantinm AB will now become part of a commercial partnership with Telix. Telix intends to integrate the platform into its therapeutic radiopharmaceutical programmes...

Visiting SNMMI 2024 in Toronto

Summer 2024 is coming up and as every year we are returning to the SNMMI 2024 in Toronto, Canada on June 8-11. Our two General Managers, Dr. Andreas Kluge and Andreas Fintelmann, and the CEO of ABX-CRO INC, Moritz Kallerhoff, will be there again accompanied by our...

Visiting Chile for TWC 2024

This year we will start our conference activities in Santiago, Chile for the 7th Theranostics World Congress. From March 22 to 24 you can find us at booth #A06 and talk with Dr. Andreas Kluge and Andreas Fintelmann, our General Managers, about how ABX-CRO can help you...

Phase 2 study for improvement of prostate cancer diagnosis

Prostate cancer awareness month may already be over, but men's health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...
Brain Perfusion or CT scan of Blood flow in the brain 3d rendering image on the screen with CT Scan room.

Expertise

With more than 20 years of experience in radiopharmaceuticals and molecular imaging, we provide solutions for radiolabelling, dosimetry, regulatory issues and the intricacies of functional imaging that are frequently seen as major obstacles in the conduct of oncology and imaging trials.

Hand turning knob to select phases of clinical trial.

Services

Our unique team of scientists and non-clinical as well as clinical research experts is there to support the development of your medicinal product or device from concept to market.

Hand turning knob to select phases of clinical trial.
Image of the human brain with the pathology

Imaging

Our dedicated Molecular and Functional Imaging Core Lab provides comprehensive turn-key solutions covering all aspects of pre-clinical and clinical Imaging and dosimetry.

Cell

Company

ABX-CRO is an independent international CRO providing standard & specialised clinical and non-clinical studies, with emphasis on neuroscience, oncology and diagnostic imaging. With a unique translational medicine approach, we are happy to develop your product from first non-clinical to late-stage multicentre human studies, or to support your marketing authorisation.

Cell
Close up of examining of test sample under the microscope in laboratory.

Looking for a job?

Do you want to be part of a team developing cutting-edge therapies and imaging solutions?
Do you want to work in a family-friendly company offering flexible solutions to suit your work-life balance?